全部

1·Notable decrease patient albuminuria;

显著减少患者蛋白尿；

2·To has the clinical albuminuria patient.

对有临床蛋白尿的患者。

3·The primary end point was a change in albuminuria.

主要终点为蛋白尿改变。

4·Dysfunction of this retrieval pathway leads to albuminuria.

而这种重吸收作用受损就会导致蛋白尿发生。

5·It enriches the thoughts for the treatment of renal albuminuria.

丰富了蛋白尿的治疗思路。

6·This association is largely independent of the level of albuminuria.

这种相关性很大程度上不依赖于蛋白尿的水平。

7·The curative effect on albuminuria was better than that on hematuria.

蛋白尿疗效优于血尿疗效。

8·The curative effect on syndrome, albuminuria and hematuria were observed.

观察证候疗效、蛋白尿和血尿疗效。

9·However, the link between early albuminuria and adiposity remains unclear.

然而，最初的蛋白尿和肥胖症之间的联系仍不清楚。

10·Fever, albuminuria, weight loss, and vomiting are the most common symptoms.

发烧，蛋白尿，体重减轻，及呕吐是最常见的症状。

蛋白尿

1·The drug is approved for treatment of hypertension but has also shown renoprotective potential in patients with type 2 diabetes and albuminuria (4, 5).

该药被批准用于治疗高血压，但也显示出在2型糖尿病和蛋白尿患者可能的肾脏保护作用(4,5)。

2·Fever, albuminuria, weight loss, and vomiting are the most common symptoms.

发烧，蛋白尿，体重减轻，及呕吐是最常见的症状。

3·Dysfunction of this retrieval pathway leads to albuminuria.

而这种重吸收作用受损就会导致蛋白尿发生。

4·However, there was no significant association between albuminuria and HF in patients taking antihypertensive treatment.

然而，在接受抗高血压药物治疗的患者中，蛋白尿和HF没有显著相关性。

5·But our patients have very low albuminuria baseline and many of them will never develop diabetic nephropathy.

我们患者的基线白蛋白尿水平本来就很低，他们中的很多人根本就不会发生糖尿病肾病。